These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 2375237)
1. Long-term bromocriptine treatment of de novo patients with Parkinson's disease. A seven-year follow-up. Bergamasco B; Benna P; Scarzella L Acta Neurol Scand; 1990 May; 81(5):383-7. PubMed ID: 2375237 [TBL] [Abstract][Full Text] [Related]
2. A randomised controlled study comparing bromocriptine to which levodopa was later added, with levodopa alone in previously untreated patients with Parkinson's disease: a five year follow up. Montastruc JL; Rascol O; Senard JM; Rascol A J Neurol Neurosurg Psychiatry; 1994 Sep; 57(9):1034-8. PubMed ID: 8089666 [TBL] [Abstract][Full Text] [Related]
3. Bromocriptine: problems with low-dose de novo therapy in Parkinson's disease. Grimes JD; Delgado MR Clin Neuropharmacol; 1985; 8(1):73-7. PubMed ID: 3978651 [TBL] [Abstract][Full Text] [Related]
4. Early combination of bromocriptine and levodopa in the treatment of Parkinson's disease: a 5-year follow-up. Rinne UK Neurology; 1987 May; 37(5):826-8. PubMed ID: 3574685 [TBL] [Abstract][Full Text] [Related]
5. Long-term double masked trial of early treatment with L-dopa plus bromocriptine versus L-dopa alone in Parkinson's disease. Interim results. Bakheit AM; Henderson LM; Moore AP; Simpson JA; Thomas M Eur Neurol; 1990; 30(2):108-11. PubMed ID: 2340834 [TBL] [Abstract][Full Text] [Related]
6. Seven-year follow-up study of bromocriptine therapy for Parkinson's disease. Yanagisawa N; Kanazawa I; Goto I; Kowa H; Kuno S; Mizuno Y; Tashiro K; Ogawa N Eur Neurol; 1994; 34 Suppl 3():29-35. PubMed ID: 7821333 [TBL] [Abstract][Full Text] [Related]
7. A randomised controlled study of bromocriptine versus levodopa in previously untreated Parkinsonian patients: a 3 year follow-up. Montastruc JL; Rascol O; Rascol A J Neurol Neurosurg Psychiatry; 1989 Jun; 52(6):773-5. PubMed ID: 2664089 [TBL] [Abstract][Full Text] [Related]
8. Nine-year follow-up study of bromocriptine monotherapy for Parkinson's disease. Kowa H; Kanazawa I; Goto I; Kuno S; Mizuno Y; Ogawa N; Tashiro K; Yanagisawa N Eur Neurol; 1997; 38 Suppl 1():23-8. PubMed ID: 9276197 [TBL] [Abstract][Full Text] [Related]
9. Eight-year follow-up study of bromocriptine monotherapy for Parkinson's disease. Tashiro K; Goto I; Kanazawa I; Kowa H; Kuno S; Mizuno Y; Ogawa N; Yanagisawa N Eur Neurol; 1996; 36 Suppl 1():32-7. PubMed ID: 8791019 [TBL] [Abstract][Full Text] [Related]
10. Progress note on Japanese multicenter bromocriptine monotherapy. Kuno S Eur Neurol; 1993; 33 Suppl 1():3-5. PubMed ID: 8375429 [TBL] [Abstract][Full Text] [Related]
11. Nationwide multicenter prospective study on the long-term effects of bromocriptine for Parkinson's disease. Final report of a ten-year follow-up. Ogawa N; Kanazawa I; Kowa H; Kuno S; Mizuno Y; Tashiro K; Yanagisawa N Eur Neurol; 1997; 38 Suppl 2():37-49. PubMed ID: 9387802 [TBL] [Abstract][Full Text] [Related]
12. The response of "de novo" Parkinson's disease patients to bromocriptine in a "low and slow" regimen is predictive for prognosis. Sampaio C; Coelho T; Castro-Caldas A; Bastos-Lima A; Levy A J Neural Transm Suppl; 1995; 45():197-202. PubMed ID: 8748626 [TBL] [Abstract][Full Text] [Related]
13. A nationwide collaborative study on the long-term effects of bromocriptine in patients with Parkinson's disease. The fourth interim report. Nakanishi T; Mizuno Y; Goto I; Iwata M; Kanazawa I; Kowa H; Mannen T; Nishitani H; Ogawa N; Takahashi A Eur Neurol; 1991; 31 Suppl 1():3-16. PubMed ID: 1906808 [TBL] [Abstract][Full Text] [Related]
14. Nation-wide collaborative study on the long-term effects of bromocriptine in the treatment of parkinsonian patients. Final report. Nakanishi T; Iwata M; Goto I; Kanazawa I; Kowa H; Mannen T; Mizuno Y; Nishitani H; Ogawa N; Takahashi A Eur Neurol; 1992; 32 Suppl 1():9-22. PubMed ID: 1425821 [TBL] [Abstract][Full Text] [Related]
15. Effects of bromocriptine on parkinsonism. A nation-wide collaborative double-blind study. Toyokura Y; Mizuno Y; Kase M; Sobue I; Kuroiwa Y; Narabayashi H; Uono M; Nakanishi T; Kameyama M; Ito H Acta Neurol Scand; 1985 Aug; 72(2):157-70. PubMed ID: 3901650 [TBL] [Abstract][Full Text] [Related]
17. [Combined treatment of the early stages of Parkinson's syndrome with bromocriptine and levodopa. The results of a multicenter study]. Fischer PA; Przuntek H; Majer M; Welzel D Dtsch Med Wochenschr; 1984 Aug; 109(34):1279-83. PubMed ID: 6381019 [TBL] [Abstract][Full Text] [Related]
18. Comparisons of therapeutic effects of levodopa, levodopa and selegiline, and bromocriptine in patients with early, mild Parkinson's disease: three year interim report. Parkinson's Disease Research Group in the United Kingdom. BMJ; 1993 Aug; 307(6902):469-72. PubMed ID: 8400928 [TBL] [Abstract][Full Text] [Related]
19. Nation-wide collaborative study on the long-term effects of bromocriptine in the treatment of parkinsonian patients: analysis on the maintenance and the change of the original mode of treatment. Nakanishi T; Kanazawa I; Iwata M; Goto I; Kowa H; Mannen T; Mizuno Y; Nishitani H; Ogawa N; Takahashi A Eur Neurol; 1992; 32 Suppl 1():23-9. PubMed ID: 1425818 [TBL] [Abstract][Full Text] [Related]
20. Combined bromocriptine-levodopa therapy early in Parkinson's disease. Rinne UK Neurology; 1985 Aug; 35(8):1196-8. PubMed ID: 4022354 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]